Second, this study only analyzed the expression level of RBM10 in LUAD tumor tissues and normal control via bioinformatics analysis, but has not yet analyzed the expression level of RBM10 in clinical specimens of lung adenocarcinoma and the correlation between its expression and clinicopathological features by IHC and requires to be explored in the future. Here, RBM10 is linked to lung adenocarcinoma.